Ultrasound Guided Radiofrequency Ablation of the Occipital Nerve

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Study an ultrasound guided approach to radiofrequency ablation of the occipital nerve that makes it possible to see the needle during treatment procedure. It is hoped this will reduce the amount of pain after the standard of care procedure.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Patients between the ages of 18-80 with a diagnosis of occipital neuralgia or migraine overlying the occipital region.

• A diagnosis of occipital neuralgia will be based on the International Classification of Headache Disorders (ICHD), whose criteria include: paroxysmal stabbing pain in the distribution of the GON, tenderness over the affected nerve, and relief of pain for at least 3 hours after bupivacaine local anesthetic block of the affected nerve.

• Patients may also be included if they have a diagnosis of migraine based on the ICHD criteria with predominance of pain over the occipital region that responded to occipital nerve block.

• Patients must have failed oral medications including NSAIDs, opioids, and anticonvulsants for the management of their pain.

• Failed treatment will be \<50% pain reduction with oral medication.

• Patients must report headache frequency of at least 10 days per month.

Locations
United States
Kansas
University of Kansas Medical Center
RECRUITING
Kansas City
Contact Information
Primary
Timothy Sowder, MD
tsowder@kumc.edu
913-588-6670
Backup
Manuel Clark
mclark16@kumc.edu
913-945-5763
Time Frame
Start Date: 2022-07-01
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 20
Treatments
Experimental: Ultrasound Guided Approach
Ultrasound-guided approach to occipital nerve radiofrequency ablation
Related Therapeutic Areas
Sponsors
Leads: University of Kansas Medical Center

This content was sourced from clinicaltrials.gov